-
Je něco špatně v tomto záznamu ?
Biomarkers of Tolerance in Kidney Transplantation: Are We Predicting Tolerance or Response to Immunosuppressive Treatment
I. Rebollo-Mesa, E. Nova-Lamperti, P. Mobillo, M. Runglall, S. Christakoudi, S. Norris, N. Smallcombe, Y. Kamra, R. Hilton, . , S. Bhandari, R. Baker, D. Berglund, S. Carr, D. Game, S. Griffin, PA. Kalra, R. Lewis, PB. Mark, S. Marks, I. Macphee,...
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
Odkazy
PubMed
27328267
DOI
10.1111/ajt.13932
Knihovny.cz E-zdroje
- MeSH
- B-lymfocyty účinky léků imunologie metabolismus MeSH
- biologické markery metabolismus MeSH
- chronické selhání ledvin komplikace chirurgie MeSH
- dospělí MeSH
- hodnoty glomerulární filtrace MeSH
- imunologická tolerance účinky léků imunologie MeSH
- imunosupresiva terapeutické užití MeSH
- lidé středního věku MeSH
- lidé MeSH
- následné studie MeSH
- přežívání štěpu účinky léků imunologie MeSH
- prognóza MeSH
- prospektivní studie MeSH
- rejekce štěpu diagnóza farmakoterapie etiologie metabolismus MeSH
- rizikové faktory MeSH
- senioři MeSH
- studie případů a kontrol MeSH
- transplantace ledvin škodlivé účinky MeSH
- vyšetření funkce ledvin MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
We and others have previously described signatures of tolerance in kidney transplantation showing the differential expression of B cell-related genes and the relative expansions of B cell subsets. However, in all of these studies, the index group-namely, the tolerant recipients-were not receiving immunosuppression (IS) treatment, unlike the rest of the comparator groups. We aimed to assess the confounding effect of these regimens and develop a novel IS-independent signature of tolerance. Analyzing gene expression in three independent kidney transplant patient cohorts (232 recipients and 14 tolerant patients), we have established that the expression of the previously reported signature was biased by IS regimens, which also influenced transitional B cells. We have defined and validated a new gene expression signature that is independent of drug effects and also differentiates tolerant patients from healthy controls (cross-validated area under the receiver operating characteristic curve [AUC] = 0.81). In a prospective cohort, we have demonstrated that the new signature remained stable before and after steroid withdrawal. In addition, we report on a validated and highly accurate gene expression signature that can be reliably used to identify patients suitable for IS reduction (approximately 12% of stable patients), irrespective of the IS drugs they are receiving. Only a similar approach will make the conduct of pilot clinical trials for IS minimization safe and hence allow critical improvements in kidney posttransplant management.
Cardiff and Vale University Health Board Cardiff United Kingdom
Evelina London Children's Hospital London United Kingdom
Great Ormond Street Hospital for Children NHS Foundation Trust London United Kingdom
Guy's and St Thomas' NHS Foundation Trust London United Kingdom
Hospital Universitari Vall d'Hebr_on Barcelona Spain
Hull and East Yorkshire Hospitals NHS Trust Hull United Kingdom
King's College Hospital NHS Foundation Trust London United Kingdom
Leicester General Hospital Leicester United Kingdom
Manchester Royal Infirmary Manchester United Kingdom
Medical Research Council Centre for Transplantation King's College London London United Kingdom
Northern General Hospital Sheffield United Kingdom
Queen Alexandra Hospital Portsmouth United Kingdom
Salford Royal Hospital Salford United Kingdom
St George's Hospital London United Kingdom
St James's University Hospital Leeds United Kingdom
Transplantační laboratoř IKEM Prague Czech Republic
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18011150
- 003
- CZ-PrNML
- 005
- 20210317132204.0
- 007
- ta
- 008
- 180404s2016 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/ajt.13932 $2 doi
- 035 __
- $a (PubMed)27328267
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Rebollo-Mesa, I $u Medical Research Council Centre for Transplantation, King's College London, London, United Kingdom. Biostatistics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom. UCB Celltech, UCB Pharma S.A., Slough, United Kingdom.
- 245 10
- $a Biomarkers of Tolerance in Kidney Transplantation: Are We Predicting Tolerance or Response to Immunosuppressive Treatment / $c I. Rebollo-Mesa, E. Nova-Lamperti, P. Mobillo, M. Runglall, S. Christakoudi, S. Norris, N. Smallcombe, Y. Kamra, R. Hilton, . , S. Bhandari, R. Baker, D. Berglund, S. Carr, D. Game, S. Griffin, PA. Kalra, R. Lewis, PB. Mark, S. Marks, I. Macphee, W. McKane, MG. Mohaupt, R. Pararajasingam, SP. Kon, D. Serón, MD. Sinha, B. Tucker, O. Viklický, RI. Lechler, GM. Lord, MP. Hernandez-Fuentes,
- 520 9_
- $a We and others have previously described signatures of tolerance in kidney transplantation showing the differential expression of B cell-related genes and the relative expansions of B cell subsets. However, in all of these studies, the index group-namely, the tolerant recipients-were not receiving immunosuppression (IS) treatment, unlike the rest of the comparator groups. We aimed to assess the confounding effect of these regimens and develop a novel IS-independent signature of tolerance. Analyzing gene expression in three independent kidney transplant patient cohorts (232 recipients and 14 tolerant patients), we have established that the expression of the previously reported signature was biased by IS regimens, which also influenced transitional B cells. We have defined and validated a new gene expression signature that is independent of drug effects and also differentiates tolerant patients from healthy controls (cross-validated area under the receiver operating characteristic curve [AUC] = 0.81). In a prospective cohort, we have demonstrated that the new signature remained stable before and after steroid withdrawal. In addition, we report on a validated and highly accurate gene expression signature that can be reliably used to identify patients suitable for IS reduction (approximately 12% of stable patients), irrespective of the IS drugs they are receiving. Only a similar approach will make the conduct of pilot clinical trials for IS minimization safe and hence allow critical improvements in kidney posttransplant management.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a B-lymfocyty $x účinky léků $x imunologie $x metabolismus $7 D001402
- 650 _2
- $a biologické markery $x metabolismus $7 D015415
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a následné studie $7 D005500
- 650 _2
- $a hodnoty glomerulární filtrace $7 D005919
- 650 _2
- $a rejekce štěpu $x diagnóza $x farmakoterapie $x etiologie $x metabolismus $7 D006084
- 650 _2
- $a přežívání štěpu $x účinky léků $x imunologie $7 D006085
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunologická tolerance $x účinky léků $x imunologie $7 D007108
- 650 _2
- $a imunosupresiva $x terapeutické užití $7 D007166
- 650 _2
- $a chronické selhání ledvin $x komplikace $x chirurgie $7 D007676
- 650 _2
- $a vyšetření funkce ledvin $7 D007677
- 650 _2
- $a transplantace ledvin $x škodlivé účinky $7 D016030
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a rizikové faktory $7 D012307
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Nova-Lamperti, E $u Medical Research Council Centre for Transplantation, King's College London, London, United Kingdom.
- 700 1_
- $a Mobillo, P $u Medical Research Council Centre for Transplantation, King's College London, London, United Kingdom.
- 700 1_
- $a Runglall, M $u National Institute for Health Research Biomedical Research Centre, Guy's and St. Thomas' National Health Service Foundation Trust, King's College London, London, United Kingdom.
- 700 1_
- $a Christakoudi, S $u Medical Research Council Centre for Transplantation, King's College London, London, United Kingdom. Biostatistics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
- 700 1_
- $a Norris, S $u Medical Research Council Centre for Transplantation, King's College London, London, United Kingdom. University College London, London, United Kingdom.
- 700 1_
- $a Smallcombe, N $u Medical Research Council Centre for Transplantation, King's College London, London, United Kingdom.
- 700 1_
- $a Kamra, Y $u Medical Research Council Centre for Transplantation, King's College London, London, United Kingdom. Peter Gorer Department of Immunobiology, King's College London, London, United Kingdom.
- 700 1_
- $a Hilton, R $u Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
- 700 1_
- $a , $u King's College London, London, United Kingdom. Oxford University, Oxford, United Kingdom. Imperial College London, London, United Kingdom. Institute for Medical Immunology, Université Libre de Bruxelles, Bruxelles, Belgium. Miltenyi Biotec, Bergisch Gladbach, Germany. University of Nantes, Nantes, France. Charité, Universitaatsmedizin Berlin, Berlin, Germany.
- 700 1_
- $a Bhandari, S $u Hull and East Yorkshire Hospitals NHS Trust, Hull, United Kingdom.
- 700 1_
- $a Baker, R $u St. James's University Hospital, Leeds, United Kingdom.
- 700 1_
- $a Berglund, D $u Uppsala University Hospital, Uppsala, Sweden.
- 700 1_
- $a Carr, S $u Leicester General Hospital, Leicester, United Kingdom.
- 700 1_
- $a Game, D $u Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
- 700 1_
- $a Griffin, S $u Cardiff and Vale University Health Board, Cardiff, United Kingdom.
- 700 1_
- $a Kalra, P A $u Salford Royal Hospital, Salford, United Kingdom.
- 700 1_
- $a Lewis, R $u Queen Alexandra Hospital, Portsmouth, United Kingdom.
- 700 1_
- $a Mark, P B $u University of Glasgow, Glasgow, United Kingdom.
- 700 1_
- $a Marks, S $u Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom.
- 700 1_
- $a MacPhee, Iain A. M., $7 xx0232048 $u St. George's Hospital, London, United Kingdom.
- 700 1_
- $a McKane, W $u Northern General Hospital, Sheffield, United Kingdom.
- 700 1_
- $a Mohaupt, M G $u INSELSPITAL, Universitätsspital Bern, Klinik für Nephrologie/Hypertonie Abteilung für Hypertonie, Bern, Switzerland.
- 700 1_
- $a Pararajasingam, R $u Manchester Royal Infirmary, Manchester, United Kingdom.
- 700 1_
- $a Kon, S P $u King's College Hospital NHS Foundation Trust, London, United Kingdom.
- 700 1_
- $a Serón, D $u Hospital Universitari Vall d'Hebr_on, Barcelona, Spain.
- 700 1_
- $a Sinha, M D $u Evelina London Children's Hospital, London, United Kingdom.
- 700 1_
- $a Tucker, B $u King's College Hospital NHS Foundation Trust, London, United Kingdom.
- 700 1_
- $a Viklický, O $u Transplantační laboratoř IKEM, Prague, Czech Republic.
- 700 1_
- $a Lechler, Robert, $u Medical Research Council Centre for Transplantation, King's College London, London, United Kingdom. King's Health Partners, London, United Kingdom. $d 1951- $7 xx0258392
- 700 1_
- $a Lord, G M $u Medical Research Council Centre for Transplantation, King's College London, London, United Kingdom. National Institute for Health Research Biomedical Research Centre, Guy's and St. Thomas' National Health Service Foundation Trust, King's College London, London, United Kingdom. Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
- 700 1_
- $a Hernandez-Fuentes, M P $u Medical Research Council Centre for Transplantation, King's College London, London, United Kingdom. National Institute for Health Research Biomedical Research Centre, Guy's and St. Thomas' National Health Service Foundation Trust, King's College London, London, United Kingdom.
- 773 0_
- $w MED00006447 $t American journal of transplantation official journal of the American Society of Transplantation and the American Society of Transplant Surgeons $x 1600-6143 $g Roč. 16, č. 12 (2016), s. 3443-3457
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27328267 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180404 $b ABA008
- 991 __
- $a 20210317132115 $b ABA008
- 999 __
- $a ok $b bmc $g 1288635 $s 1007962
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 16 $c 12 $d 3443-3457 $e 20160808 $i 1600-6143 $m American journal of transplantation $n Am J Transplant $x MED00006447
- LZP __
- $a Pubmed-20180404